Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: Proposed Acquisition of ResApp Health by Pfizer, page-387

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 387 Last

Share
Profile

Follow
BrightGreenGlow

3,648 Posts.

297

11/04/22

20:39

Post #: 60792735
Share

Originally posted by DickyB: ↑

I just had a good chat with Brian. He confirmed that the offer was subject to the board recommending it. Without them recommending it there would have been no offer. This is standard procedure with such offers. If I was Pfizer I'd do the same thing.

I think we all need to remain calm, put emotions to one side and be smart here. Pfizer are remaining calm and playing smart. There needs to be more than 75% voting yes to the offer for it to go through. I personally hold more than 1% of the shares in the company so we only need another 24% to vote no. Surely we can get 24% to vote no. We have the power here if we're smart.

We get $3,000,000 in cash immediately. If the deal get's voted down we keep the cash. Do we really think this is their best offer? Keep calm and vote no and more shares if you can. GLTAH

Expand

Woah, congrats on being a millionaire! Whale alerts!!

RAP Price at posting: 11.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 301 more messages in this thread...

First 387 Last

Add RAP (ASX) to my watchlist